 
|
Bextra and the FDAIn February of 2005 an FDA advisory panel recommended the FDA allow Bextra and Celebrex to remain on the market, though most experts agreed the drugs presented potentially fatal heart attack and stroke risks. However, the FDA elected to pull Bextra from the market. This was a break from usual practice, as the FDA usually goes along with advisory panel recommendations.
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
LifeTips is part of ideaLaunch, the hub for a group of websites offering
solutions that help clients improve mind share, market share and profit online.
solutions that help clients improve mind share, market share and profit online.
Privacy Guaranteed.
Satisfaction Required.
Satisfaction Required.
